08:00 , Feb 3, 2014 |  BioCentury  |  Finance

Bicoastal incubation

Bicoastal incubation In parallel with raising a fourth fund, the new CEO of Accelerator Corp. plans to expand the bioincubator's presence beyond Seattle by setting up shop in New York, a region he believes offers...
07:00 , Sep 26, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer E1A binding protein p300 (EP300; p300) Studies in mice suggest inhibiting p300 could help treat cancer by promoting antitumor immunity....
07:00 , May 28, 2012 |  BioCentury  |  Finance

Pressing the Accelerator

Pressing the Accelerator Venture-backed incubator Accelerator Corp. is raising a fourth fund that it expects to close by year end, Chairman and CEO Carl Weissman told BioCentury. Weissman, who also is a managing director at...
07:00 , Sep 5, 2011 |  BioCentury  |  Strategy

Back to School: Innovation & collaboration

Since the economic downturn of 2008, doom has become ingrained in the biopharma narrative. According to the mantra, budgets for great science have flatlined. New startups can't find VC money to translate great science because...
08:00 , Dec 9, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine disease Diabetes; obesity Ghrelin O-Acyltransferase (GOAT) In vitro and mouse studies suggest that inhibiting GOAT could help treat endocrine disorders including obesity and diabetes. In...
08:00 , Dec 9, 2010 |  BC Innovations  |  Targets & Mechanisms

Going for GOAT

A team led by researchers from The Johns Hopkins University has developed the first biologically active inhibitors of ghrelin O -acyltransferase-a recently discovered enzyme that activates the appetite-stimulating hormone ghrelin. The inhibitors are licensed to...
08:00 , Dec 6, 2010 |  BC Week In Review  |  Financial News

Acylin Therapeutics completes venture financing

Acylin Therapeutics Inc. , Seattle, Wash.   Business: Cancer, Metabolic, Neurology   Date completed: 12/1/10   Type: Venture financing   Raised: Not disclosed   Investors: Accelerator Corp. ; Alexandria Real Estate Equities; Amgen Ventures; Arch...